Carbon Radioisotopes

DrugDrug NameDrug Indication
DB00370MirtazapineFor the treatment of major depressive disorder.
DB01535CarfentanilCarfentanil is similar (but more potent) to the opioid analgesic fentanyl. It is used as a tranquilizer for large animals.
DB02216S-MethylcysteineNot Available
DB023422-MethoxyestradiolFor the treatment of breast cancer and inflammatory diseases such as rheumatoid arthritis.
DB03656Tribenuron MethylNot Available
DB06261HexaminolevulinateHexaminolevulinate is indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy.
DB06618CutamesineInvestigated for use/treatment in strokes and depression.
DB06678EsmirtazapineInvestigated for use/treatment in insomnia and sleep disorders.
DB08824Ioflupane I-123Ioflupane I-123 is a SPECT (single photon emission computerized tomography) agent used to distinguish between Parkinson’s syndrome tremors and essential tremor.
DB09190TalopramNot Available
DB11665BMS-690514Not Available
DB11798TanzisertibNot Available
DB12060RRx-001Not Available
DB12799LaniquidarNot Available
DB09510Urea C-13Urea-13C is indicated for use in the qualitative detection of urease associated with Helicobacter pylori in the human stomach and as an aid in the initial diagnosis and post-treatment monitoring of Helicobacter pylori infection in adult patients. The test may be used for monitoring treatment if used at least four (4) weeks following completion of therapy. For these purposes, the system utilizes an Infrared Spectrophotometer for the measurement of the ratio of 13CO2 to 12CO2 in breath samples.
DrugDrug NameTargetType
DB00370Mirtazapine5-hydroxytryptamine receptor 2Atarget
DB00370Mirtazapine5-hydroxytryptamine receptor 3Atarget
DB00370MirtazapineAlpha-2A adrenergic receptortarget
DB00370Mirtazapine5-hydroxytryptamine receptor 2Ctarget
DB00370MirtazapineKappa-type opioid receptortarget
DB00370MirtazapineHistamine H1 receptortarget
DB00370MirtazapineCytochrome P450 1A2enzyme
DB00370MirtazapineCytochrome P450 3A4enzyme
DB00370MirtazapineCytochrome P450 2D6enzyme
DB00370MirtazapineCytochrome P450 2C8enzyme
DB00370MirtazapineCytochrome P450 2C9enzyme
DB00370MirtazapineAlpha-2C adrenergic receptortarget
DB00370Mirtazapine5-hydroxytryptamine receptor 7target
DB00370MirtazapineAlpha-1 adrenergic receptorstarget
DB00370MirtazapineD(2) dopamine receptortarget
DB00370MirtazapineD(3) dopamine receptortarget
DB00370MirtazapineSodium-dependent noradrenaline transportertarget
DB00370MirtazapineSodium-dependent serotonin transportertarget
DB00370MirtazapineSodium-dependent dopamine transportertarget
DB00370Mirtazapine5-hydroxytryptamine receptor 2Btarget
DB00370MirtazapineD(1) dopamine receptortarget
DB00370MirtazapineHistamine H3 receptortarget
DB00370MirtazapineAlpha-1A adrenergic receptortarget
DB00370MirtazapineBeta-1 adrenergic receptortarget
DB00370MirtazapineBeta-2 adrenergic receptortarget
DB01535CarfentanilMu-type opioid receptortarget
DB01535CarfentanilKappa-type opioid receptortarget
DB01535CarfentanilDelta-type opioid receptortarget
DB02216S-MethylcysteineCathepsin Dtarget
DB02216S-MethylcysteineFatty acid-binding protein, livercarrier
DB02216S-MethylcysteineMethylated-DNA--protein-cysteine methyltransferasetarget
DB023422-MethoxyestradiolHypoxia-inducible factor 1-alphatarget
DB023422-MethoxyestradiolSex hormone-binding globulincarrier
DB023422-MethoxyestradiolCatechol O-methyltransferasetarget
DB023422-MethoxyestradiolCytochrome P450 1A1target
DB023422-MethoxyestradiolCytochrome P450 1B1target
DB023422-MethoxyestradiolCytochrome P450 19A1target
DB06678EsmirtazapineCytochrome P450 2D6enzyme
DB06678EsmirtazapineHistamine H1 receptortarget
DB06678Esmirtazapine5-hydroxytryptamine receptor 2target
DB06678EsmirtazapineAlpha-2 adrenergic receptorstarget
DB08824Ioflupane I-123Sodium-dependent dopamine transportertransporter
DB09510Urea C-13Ureasetarget